ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,526,517 | -13.3% | 93,092 | -1.9% | 0.01% | -7.7% |
| Q2 2023 | $2,915,750 | -5.7% | 94,852 | +10.5% | 0.01% | -18.8% |
| Q1 2023 | $3,093,248 | -2.0% | 85,852 | +7.5% | 0.02% | -11.1% |
| Q4 2022 | $3,155,632 | -0.4% | 79,849 | +1.3% | 0.02% | -10.0% |
| Q3 2022 | $3,168,000 | +2.1% | 78,839 | +6.8% | 0.02% | +5.3% |
| Q2 2022 | $3,104,000 | +15.7% | 73,839 | +7.3% | 0.02% | +26.7% |
| Q1 2022 | $2,682,000 | -1.0% | 68,839 | +1.2% | 0.02% | +7.1% |
| Q4 2021 | $2,710,000 | +140.2% | 68,009 | +118.0% | 0.01% | +133.3% |
| Q3 2021 | $1,128,000 | -64.4% | 31,199 | -59.6% | 0.01% | -66.7% |
| Q2 2021 | $3,168,000 | -49.3% | 77,299 | -46.0% | 0.02% | -55.0% |
| Q1 2021 | $6,249,000 | -5.5% | 143,260 | +8.4% | 0.04% | -11.1% |
| Q4 2020 | $6,616,000 | +54.8% | 132,200 | +30.1% | 0.04% | +36.4% |
| Q3 2020 | $4,275,000 | – | 101,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 418 | $11,742 | 0.00% |
| Versant Capital Management, Inc | 20 | $562 | 0.00% |